XOMA Royalty

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XOMA Royalty and other ETFs, options, and stocks.

About XOMA

XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. 

CEO
Owen Patrick Hughes
CEOOwen Patrick Hughes
Employees
13
Employees13
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
1981
Founded1981
Employees
13
Employees13

XOMA Key Statistics

Market cap
311.81M
Market cap311.81M
Price-Earnings ratio
35.60
Price-Earnings ratio35.60
Dividend yield
Dividend yield
Average volume
87.11K
Average volume87.11K
High today
$27.50
High today$27.50
Low today
$25.07
Low today$25.07
Open price
$26.82
Open price$26.82
Volume
134.57K
Volume134.57K
52 Week high
$39.92
52 Week high$39.92
52 Week low
$18.35
52 Week low$18.35

Stock Snapshot

As of today, XOMA Royalty(XOMA) shares are valued at $25.22. The company's market cap stands at 311.81M, with a P/E ratio of 35.60.

On 2025-12-12, XOMA Royalty(XOMA) stock moved within a range of $25.07 to $27.50. With shares now at $25.22, the stock is trading +0.6% above its intraday low and -8.3% below the session's peak.

Trading volume for XOMA Royalty(XOMA) stock has reached 134.57K, versus its average volume of 87.11K.

Over the past 52 weeks, XOMA Royalty(XOMA) stock has traded between a high of $39.92 and a low of $18.35.

Over the past 52 weeks, XOMA Royalty(XOMA) stock has traded between a high of $39.92 and a low of $18.35.

XOMA News

TipRanks 12h
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated

In a report released yesterday, Robert Wasserman from Benchmark Co. maintained a Buy rating on Xoma, with a price target of $50.00. Claim 50% Off TipRanks Premi...

TipRanks 1d
Xoma price target lowered to $97 from $104 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on Xoma (XOMA) to $97 from $104 and keeps a Buy rating on the shares after removing ers...

TipRanks 4d
Xoma initiated with a Buy at Lucid Capital

Lucid Capital initiated coverage of Xoma (XOMA) with a Buy rating and $76 price target The company has assembled a royalty portfolio from six commercial and nin...

People also own

Based on the portfolios of people who own XOMA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.